Long-Term Liabilities: The sum of all non-current liabilities.
Hepion Pharmaceuticals, Inc. (HEPA) had Long-Term Liabilities of $5.52M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-48.93M |
|
-- |
|
-- |
|
$48.45M |
|
$-48.45M |
|
$-0.89M |
|
$-49.34M |
|
$-49.34M |
|
$-48.93M |
|
$-48.93M |
|
$-48.93M |
|
$-48.93M |
|
$-48.45M |
|
$-45.19M |
|
3.97M |
|
3.97M |
|
$-12.32 |
|
$-12.32 |
|
| Balance Sheet Financials | |
$17.49M |
|
$0.03M |
|
$0.61M |
|
$18.09M |
|
$5.29M |
|
-- |
|
|
Long-Term Liabilities |
$5.52M |
$10.81M |
|
$5.59M |
|
$7.28M |
|
$7.28M |
|
4.82M |
|
| Cash Flow Statement Financials | |
$-40.89M |
|
$-0.01M |
|
$4.50M |
|
$51.19M |
|
$14.79M |
|
$-36.40M |
|
$1.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.31 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-40.90M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-875.92% |
|
-671.99% |
|
-270.39% |
|
-671.99% |
|
$1.51 |
|
$-10.30 |
|
$-10.30 |
|